For acute injuriestorn muscles, damaged tendons, ligament strainsmost people see optimal results with twice-daily dosing (once in the morning and once in the evening)
[DOI] [Google Scholar] 42.Hsieh M.J., Lee C.H., Chueh H.Y., Chang G.J., Huang H.Y., Lin Y., Pang J.S
The results suggested that TB-500 not only potentially enhanced the viability, angiogenesis, and migratory ability of HUVEC but possibly also promoted the expression of angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), vascular endothelial growth factor A (VEGFA), NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), NF-B, and phosphorylated (p)-p65 in HUVEC
Both target weight loss through incretin pathways , but the dosage charts could not look more different
The combination of higher bioavailability, faster onset, and ability to inject near the injury site provides advantages that oral administration cannot match